Share price of the British pharmaceutical company GSK (NYSE: GSK ) has gone nowhere since I last wrote about at the end of July. Until yesterday, that is, when it spiked by ~6% following news that the company had Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green Growth Giants ...